Advancing Lymphoma Care With CAR T-Cell Therapies CME Thursday, 15 October 2026 | 12:00 PM - 12:45 PM ET | 18:00 - 18:45 CEST

https://na.eventscloud.com/website/98976/ Join our live, 45-minute webinar, "Advancing Lymphoma Care With CAR T-Cell Therapies," designed for hematology/oncology physicians, nurses, and pharmacists in the United States and Europe. Led by global experts, this session helps you safely integrate chimeric antigen receptor (CAR) T-cell therapies into your practice for B-cell lymphomas, including diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). You will learn to navigate regional approvals and clinical data, streamline patient referrals and care handoffs, and manage toxicities like cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS). The webinar ends with a 15-minute live Q&A where you can ask the experts your questions directly. Register now to help improve care and access for your patients. You will learn to navigate regional approvals and clinical data, streamline patient referrals and care handoffs, and manage toxicities like cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS). The webinar ends with a 15-minute live Q&A where you can ask the experts your questions directly. Register now to help improve care and access for your patients.

Here’s why separating MMR vaccines is a bad idea Teo Yik Ying | National University of Singapore | September 14, 2026

https://geneticliteracyproject.org/2026/09/14/heres-why-separating-mmr-vaccines-is-a-bad-idea/ Singapore has not been spared from the global resurgence of measles. As at end-July, Singapore had recorded 40 measles cases – the highest number in six years and already well above the total of 27 cases reported throughout 2025.

Fibermaxxing: Latest Instagram diet craze raises hope that a fiber-rich diet can improve health Claudia Steiner | September 14, 2026

https://geneticliteracyproject.org/2026/09/14/fibermaxxing-latest-instagram-diet-craze-raises-hope-that-a-fiber-rich-diet-can-improve-health/ In the world of dietary trends, proteinmaxxing is taking a back seat to the new obsession: ramping up on fiber. Since the summer of 2025, Instagram has racked up more than 10,000 posts captioned with #Fibermaxxing and other fiber-forward hashtags — and the flood doesn’t appear to be dissipating.

What cells can teach us about discovering better drugs By tracking how cells respond to hundreds of thousands of compounds, Soley Therapeutics aims to discover medicines for complex diseases where traditional target-based approaches often fall short. Written byBree Foster, PhD

What cells can teach us about discovering better drugs By tracking how cells respond to hundreds of thousands of compounds, Soley Therapeutics aims to discover medicines for complex diseases where traditional target-based approaches often fall short. Written byBree Foster, PhD https://www.drugdiscoverynews.com/what-cells-can-teach-us-about-discovering-better-drugs-17398?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-9R6vF9OThDDgSzCXGjblX5fEa0lI7LbYo2XvB81mHcqC9hXkZdwfkHAuoaypaWH5yoSXYbJm7BdzIF2A9Wl4JzAEPpWg&_hsmi=438910159&utm_content=438910159&utm_source=hs_email Modern drug discovery has become increasingly adept at identifying promising therapeutic targets. Advances in genomics, proteomics, and AI now allow researchers to sift through vast biomedical datasets to pinpoint proteins and pathways most likely to influence disease. Yet despite these advances, most drug candidates still fail in the clinic, often because the underlying biology proves more complex than anticipated.

You cannot understand biology by killing it Drug discovery still relies on destroying cells to understand how they respond, but new real-time measurement approaches are beginning to reveal biology in motion rather than in snapshots. Written byBree Foster, PhD May 11, 2026 | 5 min read

You cannot understand biology by killing it Drug discovery still relies on destroying cells to understand how they respond, but new real-time measurement approaches are beginning to reveal biology in motion rather than in snapshots. Written byBree Foster, PhD May 11, 2026 https://www.drugdiscoverynews.com/you-cannot-understand-biology-by-killing-it-17159?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-_92ADwkr17b9kR6cIm8jRhtvdR7Ezbyp0z15t8O-F_bP3qW3mr8-uKjmOAf-3hTg9US063U4ud68mgRxDESj1i5gaKCA&_hsmi=438910159&utm_content=438910159&utm_source=hs_email Modern drug discovery is built on a paradox. To learn how living systems respond to intervention, we routinely destroy them. Cells are lysed, fixed, stained, sequenced, averaged, and reconstructed after the fact. This gives us a snapshot of what the cells were like before and after, but tells us very little about what happened in between.

What is a virtual cell? GenBio’s virtual cell integrates multiple layers of cellular biology to predict how cells respond to drugs and genetic changes. Written byBree Foster, PhD

What is a virtual cell? GenBio’s virtual cell integrates multiple layers of cellular biology to predict how cells respond to drugs and genetic changes. Written byBree Foster, PhD https://www.drugdiscoverynews.com/what-is-a-virtual-cell-17525?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-9sP9A8MsE5wkkXrNijSktusa-W1-fnV7Ucjm-IxJOFeIr50CYh_lpfH5TxMgItOeEVfruB9PL1ChSwzZogXSO-vDJVkw&_hsmi=438910159&utm_content=438910159&utm_source=hs_email The idea of a virtual cell is not new. In the 1990s, genome scientist J. Craig Venter was already pursuing the idea of simulating an entire cell on a computer. His broader work — from helping pioneer rapid genome sequencing to creating organisms with synthetic genomes — helped lay the groundwork for thinking about biology as something that could be represented computationally.

Advancing Childhood Cancer Research: A Conversation with Dr. Brigitte Widemann September 14, 2026, by Linda Wang

https://www.cancer.gov/news-events/cancer-currents-blog/2026/childhood-cancer-research-widemann?cid=eb_govdel In recognition of Childhood Cancer Awareness Month, NCI's Dr. Brigitte Widemann discusses recent advances in treatment, shared data, artificial intelligence, research participation, and survivorship. She explains why sustained federal investment and partnerships with patients, families, advocates, and researchers are essential to continued progress.